DEF: OptimumBank Holdings Sets 2026 Annual Meeting Agenda
Proxy Statement
OptimumBank Holdings, Inc. announced its 2026 Annual Meeting of Shareholders to vote on director elections, a new class of nonvoting common stock, and auditor ratification.
Summary
- The Annual Meeting of Shareholders is scheduled for April 28, 2026, at 10:00 a.m. Eastern Time, at the company's executive offices in Fort Lauderdale, Florida.
- Shareholders will vote on the election of six directors, the approval of an amendment to authorize a class of nonvoting common stock, the ratification of Hacker, Johnson & Smith, P.A. as the independent auditor for the 2026 fiscal year, and a proposal to adjourn the meeting if necessary.
- The proposed amendment to the Articles of Incorporation would authorize up to 30,000,000 shares of nonvoting common stock, increasing the total authorized shares of all classes to 66,000,000.
- The company expects to exchange all outstanding Series B and Series C Convertible Preferred Stock for shares of the new nonvoting common stock, impacting significant holders like AllianceBernstein L.P., Michael Blisko, and Gubin Enterprises Limited Partnership.
- The Board of Directors unanimously recommends voting FOR all proposals.
- The 2018 Equity Incentive Plan is proposed to be amended to increase the number of shares available for issuance from 1,050,000 to 1,550,000 shares.
- Timothy Terry, President and CEO, received total compensation of $680,000 in 2025, an increase from $499,000 in 2024.
- Elliot Nunez, Chief Financial Officer (appointed May 2025), received total compensation of $277,000 in 2025.
- Moishe Gubin, Chairman of the Board, received $95,125 in cash fees and $579,274 in stock awards for his services as a director in 2025.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this filing as moderately positive due to proactive steps in corporate governance and capital structure flexibility, balanced by the potential for economic dilution from the new nonvoting stock class.
Positives
- The authorization of nonvoting common stock provides additional flexibility to raise capital without diluting the voting power of existing shareholders.
- It enhances the company's ability to structure strategic transactions, including acquisitions and joint ventures, and allows for more efficient responses to financing opportunities.
- The Board of Directors maintains a separation of Chairman and CEO roles, which is often viewed as a strong corporate governance practice.
- All current directors attended at least 75% of Board and committee meetings in 2025, indicating active engagement and commitment.
- The company has a clear hedging policy prohibiting directors and executive officers from speculative transactions in company securities.
Negatives
- Issuance of nonvoting common stock could lead to economic dilution for existing shareholders, potentially affecting earnings per share and book value per share if shares are issued below book value.
- The availability of authorized but unissued nonvoting common stock could have an anti-takeover effect, potentially making a change in control more difficult or discouraging unsolicited acquisition proposals.
- Executive compensation for Timothy Terry (CEO) increased significantly from $499,000 in 2024 to $680,000 in 2025, a 36% increase, which may warrant scrutiny regarding performance alignment.
- Moishe Gubin, Chairman, received substantial stock awards ($579,274) in 2025 in addition to cash compensation, which could be seen as concentrated compensation.
Risks
- Economic dilution of existing shareholders' interests (earnings per share and book value per share) if nonvoting common stock is issued below book value.
- Potential anti-takeover effect from the availability of authorized but unissued nonvoting common stock, which could make a change in control more difficult or discourage unsolicited acquisition proposals.
- The company's ability to raise capital through nonvoting common stock is subject to the rules of banking regulators concerning control of the Company and the Bank.
Future Outlook
The Board believes that authorizing nonvoting common stock will provide additional flexibility to raise capital, enhance the company's ability to structure strategic transactions, and allow for more efficient responses to financing opportunities. The company expects to exchange outstanding Series B and Series C Convertible Preferred Stock for the new nonvoting common stock, though no definitive plans for further issuance exist beyond this exchange.
Management Comments
- "Whether or not you expect to attend in person, we urge you to vote your shares via the Internet, or by signing, dating, and returning the enclosed proxy card at your earliest convenience. This will ensure the presence of a quorum at the meeting."
- "Promptly voting your shares will save us the expense and extra work of additional solicitation."
- "The Board believes that authorizing Nonvoting Common Stock is in the best interests of the Company and its shareholders because it will: Provide additional flexibility to raise capital without diluting the voting power of existing shareholders; Enhance the Companys ability to structure strategic transactions, including acquisitions and joint ventures; Provide flexibility to raise capital while adhering to the rules of the Companys banking regulators concerning control of the Company and the Bank; and Allow the Company to respond more efficiently to financing opportunities without the delay and expense of seeking further shareholder approval, except as required by law or NYSE American rules."
- "The Board is not aware of any current effort to obtain control of the Company and has no present intention of using the authorization of Nonvoting Common Stock for anti-takeover purposes."
- "The Board believes the increased flexibility outweighs any potential anti-takeover impact."
Industry Context
StockSavvy.ai notes that the proposal to authorize nonvoting common stock is a strategic move often employed by companies, particularly in regulated sectors like banking, to gain capital-raising flexibility while maintaining existing control structures. This approach can be attractive for growth initiatives or balance sheet strengthening without immediate voting dilution, a common concern for existing shareholders. The increase in executive compensation, particularly for the CEO, should be evaluated against peer performance and industry benchmarks for similar-sized regional banks.
Comparison to Industry Standards
- The authorization of nonvoting common stock is a common strategy in the banking sector, similar to structures seen in larger financial institutions like JPMorgan Chase or Bank of America, which use various equity instruments to manage capital and control. However, for a smaller entity like OptimumBank Holdings, the impact of such a class on market perception and liquidity could differ.
- The proposed exchange of Series B and C Convertible Preferred Stock for nonvoting common stock is a specific capital restructuring event, not directly comparable to broad industry benchmarks but rather to similar recapitalization efforts by other regional banks seeking to simplify their capital structure or prepare for future funding rounds.
- The increase in CEO compensation from $499,000 to $680,000 (36%) for Timothy Terry in 2025 should be benchmarked against compensation trends for CEOs of similarly sized community banks in the Florida market, considering factors like asset growth, profitability, and shareholder returns. Without specific peer data, it's difficult to assess if this is above or below industry standards.
- Audit fees increasing from $105,000 in 2024 to $119,500 in 2025 (13.8%) are generally in line with inflationary pressures and increased regulatory scrutiny in the financial services industry, which often leads to higher audit engagement costs.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Financial Officer (Company) | NA | Elliot Nunez | May 2025 | Appointment to the role for the Company, having previously served as CFO of the Bank since February 2020. |
| Director | Martin Schmidt | NA | January 28, 2025 | Cessation of service on the board. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Proposed Amendment to Articles of Incorporation | Authorization of a new class of Nonvoting Common Stock, par value $0.01 per share, up to 30,000,000 shares. This includes an increase in the aggregate number of shares of all classes to 66,000,000 (30M voting common, 30M nonvoting common, 6M preferred). | April 28, 2026 (upon shareholder approval) | Provides greater flexibility for capital raises and strategic transactions without diluting existing shareholders' voting power, but introduces potential for economic dilution and anti-takeover effects. |
| Proposed Amendment to 2018 Equity Incentive Plan | Increase in the number of shares of common stock that may be issued under the plan from 1,050,000 shares to 1,550,000 shares. | April 28, 2026 (upon shareholder approval) | Enhances the company's ability to attract and retain qualified directors and officers through equity compensation, potentially increasing share-based compensation expenses. |
| Director Independence Assessment | The Board determined that Michael Blisko, Moishe Gubin, Steve Newman, Thomas Procelli, and Avi Zwelling meet NYSE American independence standards. Joel Klein does not. | Ongoing (as of 2025 review) | Maintains compliance with listing standards and supports independent oversight, with a majority of independent directors on key committees. |
| Board Leadership Structure | The company's policy is to separate the roles of Chairman (Moishe Gubin) and principal executive officer. | Ongoing | Promotes independent oversight and reduces potential conflicts of interest, aligning with best practices in corporate governance. |
| Hedging Policy | The Insider Trading Policy prohibits directors and executive officers from engaging in hedging or other speculative transactions involving the company's securities. | Ongoing | Reduces potential for conflicts of interest and promotes alignment of insider interests with long-term shareholder value. |
Related Party Transactions
- No transactions exceeding $120,000 since January 1, 2025, in which a director, executive officer, or 5%+ shareholder had a direct or indirect material interest, other than loans.
- Loans to officers, directors, and affiliates were made in the ordinary course of business on substantially the same terms (interest rates, collateral) as comparable transactions with unrelated parties, and complied with Bank policy and statutory lending limits.
- Michael Blisko and Moishe Gubin have an interest in the proposal to authorize nonvoting common stock due to their beneficial ownership of Series B Convertible Preferred Stock, which is expected to be exchanged for the new nonvoting common stock.
Stakeholder Impact
- Shareholders (Voting): Voting power will not be diluted by the issuance of nonvoting common stock, but economic interests (EPS, book value) could be diluted if shares are issued below book value. The authorization provides the company with greater flexibility for future capital raises and strategic transactions, which could benefit long-term value.
- Shareholders (Preferred Stock): Holders of Series B and Series C Convertible Preferred Stock (e.g., AllianceBernstein L.P., Michael Blisko, Gubin Enterprises Limited Partnership) are expected to exchange their shares for the new nonvoting common stock, which will alter their equity structure in the company.
- Management/Directors: The proposed increase in shares available under the 2018 Equity Incentive Plan provides more capacity for equity compensation, potentially aiding in attraction and retention. Executive compensation for the CEO saw a significant increase in 2025.
- Potential Investors: The availability of nonvoting common stock could make the company more attractive for certain types of investors seeking economic exposure without voting control, potentially broadening the investor base.
Next Steps
- Shareholders to vote on the election of six directors at the Annual Meeting on April 28, 2026.
- Shareholders to vote on the amendment to authorize a class of nonvoting common stock.
- Shareholders to vote on the ratification of Hacker, Johnson & Smith, P.A. as the independent auditor for the 2026 fiscal year.
- Shareholders to vote on the proposal to adjourn the annual meeting in the event there are insufficient votes to approve one or more of the foregoing proposals.
- The company expects to exchange outstanding Series B and Series C Convertible Preferred Stock for the newly authorized nonvoting common stock if the amendment is approved.
- Shareholders wishing to submit proposals for the 2027 annual meeting must do so by November 24, 2026 (for inclusion in proxy materials) or January 1, 2027 (for other proposals/nominations).
Key Dates
| Date | Description |
|---|---|
| 2000-10-01 | Founding of OptimumBank. |
| 2002-01-01 | Steven Newman founded The Newman Group, LLC. |
| 2004-01-01 | Moishe Gubin became CFO and manager of Infinity Healthcare Management, LLC. |
| 2008-01-01 | Moishe Gubin became CEO of Strawberry Fields REIT, Inc. and its predecessor. |
| 2010-03-01 | Moishe Gubin became a director of the Company and OptimumBank. |
| 2010-01-01 | Moishe Gubin became a licensed Certified Public Accountant in New York. |
| 2010-01-01 | Joel Klein became a private investor. |
| 2012-02-01 | Joel Klein became a director of the Company and OptimumBank. |
| 2012-01-01 | Avi Zwelling began providing legal services to the Company. |
| 2013-02-01 | Timothy Terry appointed President and Chief Executive Officer of the Bank. |
| 2014-01-01 | Moishe Gubin ceased being CFO and manager of Infinity Healthcare Management, LLC. |
| 2015-01-01 | Steven Newman founded Freight Factoring Specialists, LLC. |
| 2015-09-01 | Thomas Procelli ceased serving as Executive Vice President, Chief Technology Officer, and Chief Operating Officer of OptimumBank. |
| 2016-06-01 | Timothy Terry began serving as the Company's principal executive officer. |
| 2017-07-01 | Thomas Procelli became a director of the Company. |
| 2017-12-01 | Avi M. Zwelling became a director of the Company and OptimumBank. |
| 2020-02-01 | Elliot Nunez appointed Executive Vice President and Chief Financial Officer of the Bank. |
| 2021-05-01 | Michael Blisko became a director. |
| 2022-08-01 | Steven Newman became a director of the Company and OptimumBank. |
| 2023-12-31 | End of fiscal year for which Timothy Terry's compensation was $415,000. |
| 2024-12-31 | End of fiscal year for which Timothy Terry's compensation was $499,000 and audit fees were $105,000. |
| 2025-01-01 | Start of period for related party transaction disclosure. |
| 2025-01-28 | Martin Schmidt ceased serving on the board. |
| 2025-04-29 | Date of the 2025 annual meeting, attended by all current directors. |
| 2025-05-01 | Elliot Nunez appointed Chief Financial Officer for the Company. |
| 2025-12-31 | End of fiscal year for which audited financial statements were reviewed, Timothy Terry's compensation was $680,000, Elliot Nunez's compensation was $277,000, and audit fees were $119,500. |
| 2026-03-09 | Record Date for shareholders entitled to vote at the 2026 annual meeting. |
| 2026-03-24 | Proxy Statement first mailed to shareholders on or about this date. |
| 2026-03-24 | Date of the Notice of Annual Meeting of Shareholders. |
| 2026-04-27 | Deadline for Internet voting (11:59 p.m. Eastern Time). |
| 2026-04-28 | Date of the 2026 Annual Meeting of Shareholders. |
| 2026-11-24 | Deadline for shareholder recommendations for director nominees for the 2027 annual meeting. |
| 2027-01-01 | Deadline for shareholders to give advance written notice for other proposals at the 2027 annual meeting not intended for proxy statement inclusion. |
| 2027-01-01 | Target date for the 2027 annual meeting and election of successors for directors. |
Recommendation
holdThe filing primarily addresses routine corporate governance matters and a strategic proposal for capital structure flexibility. While the authorization of nonvoting common stock offers potential benefits for future capital raises and strategic transactions, it also introduces potential economic dilution and anti-takeover effects. There are no immediate financial results or significant operational changes disclosed that would warrant a strong buy or sell recommendation. The company appears to be taking steps to enhance its long-term financial agility, but the immediate impact on shareholder value is neutral, suggesting a 'hold' position for existing investors to observe the execution of these strategic initiatives.
Keywords
OptimumBank Holdings, OBNK, Proxy Statement, Annual Meeting, Nonvoting Common Stock, Capital Raise, Corporate Governance, Director Election, Auditor Ratification, Shareholder Vote, SEC Filing, Equity Incentive Plan, Executive Compensation, Banking Industry
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.